Business Context and Reporting Period
This Form 8-K was filed by ReWalk Robotics Ltd. on May 9, 2019. The registrant is an emerging growth company incorporated in Israel, with its principal executive offices located in Yokneam Ilit, Israel. The company trades on the Nasdaq Capital Market under the symbol "RWLK."
Key Financial Metrics
This filing does not report specific financial performance metrics such as revenue, profit, cash flow, margins, or debt levels. The document focuses exclusively on a corporate agreement regarding equity distribution. For detailed financial data, the filing references the Company's Annual Report on Form 10-K filed on February 8, 2019, and the Quarterly Report on Form 10-Q filed on May 8, 2019.
Material Changes
On May 9, 2019, the Company entered into Amendment No. 1 to its Equity Distribution Agreement with Piper Jaffray & Co. The primary material change is the extension of the agreement's term by three years. The amendment also includes certain conforming changes, while the core terms of the agreement remain substantially unchanged.
Guidance, Outlook, and Risks
The filing does not provide new financial guidance, management commentary on future operations, or specific risk factors beyond the terms of the amended agreement. Under the amended agreement, the Company may offer and sell ordinary shares with an aggregate offering price of up to $25.0 million through "at-the-market" offerings. The agreement will terminate upon the earliest of: (i) the sale of all shares subject to the agreement, (ii) three years after a new Form S-3 registration statement becomes effective, (iii) the Company becoming ineligible to use Form S-3, or (iv) termination by the parties.
Investor Verification Checklist
- Verify the remaining aggregate offering price available under the $25.0 million Equity Distribution Agreement.
- Review the Form 10-Q filed on May 8, 2019, for the most recent liquidity and capital resources data.
- Confirm the Company's continued eligibility to use Form S-3 for future offerings.
- Monitor the Company's share price and volume to assess potential dilution from future "at-the-market" sales.